In March 2015, FDA approved LIXELLE as a Class III Humanitarian Use Device (HUD) with an approved Humanitarian Device Exemption (HDE)
10.1083/jcb.126.2.485 J
Khavinson VKh, Pendina AA, Efimova OA, Tikhonov AV, Koltsova AS, Krapivin MI, et al
It is particularly beneficial for livestock or pets experiencing poor growth, weight loss, or decreased productivity due to dietary insufficiencies or underlying health conditions
Caplan tried PT-141 herself years ago when it was still experimental her experience was underwhelming, but the compound eventually completed clinical trials and reached the market under proper regulation
For CY 2026, the OPPS payment rates were proposed to be based on available CY 2024 claims data